ERK and cell death: ERK1/2 in neuronal death

FEBS Journal

Volumn 277, Issue 1, 2010, Pages 22-29

  Subramaniam, Srinivasa ^a   Unsicker, Klaus ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Akt PKB; Apoptosis; Caspase; Cell survival; ERK; Ischemia; Neurodegenerative disease; Neuronal death; Sustained ERK; Transient ERK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; APOPTOSIS REGULATORY PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL; CARRIER PROTEIN; CASPASE; CYCLIN DEPENDENT KINASE 5; EPIDERMAL GROWTH FACTOR; FAS LIGAND; GLUTAMIC ACID; HYDROGEN PEROXIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; BRAIN NUCLEUS; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL SURFACE; CELL SURVIVAL; CELL TYPE; CHOLINERGIC NERVE CELL; CYTOPLASM; DEGENERATIVE DISEASE; DENTATE GYRUS; DNA DEGRADATION; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DROSOPHILA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FOREBRAIN; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; IMMUNOREACTIVITY; LIGAND BINDING; MEDULLOBLASTOMA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PURKINJE CELL; SHORT SURVEY; SIGNAL TRANSDUCTION; STRIATE CORTEX; TRAUMATIC BRAIN INJURY;

ANIMALS; CELL DEATH; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; ISCHEMIA; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 73649091056     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07367.x     Document Type: Short Survey

References (72)

1. Andrabi SA, Dawson TM Dawson VL (2008) Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann NY Acad Sci 1147, 233 241.
2. Leadsham JE Gourlay CW (2008) Cytoskeletal induced apoptosis in yeast. Biochim Biophys Acta 1783, 1406 1412.
3. Lorz C Mehmet H (2009) The role of death receptors in neural injury. Front Biosci 14, 583 595.
4. Tait SW Green DR (2008) Caspase-independent cell death: leaving the set without the final cut. Oncogene 27, 6452 6461.
5. Subramaniam S Unsicker K (2006) Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death. Neuroscience 138, 1055 1065.
6. Johnson EM Jr. Deckwerth TL (1993) Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 16, 31 46.
7. Cavanaugh JE (2004) Role of extracellular signal regulated kinase 5 in neuronal survival. Eur J Biochem 271, 2056 2059.
8. Wang RM, Zhang QG, Li CH Zhang GY (2005) Activation of extracellular signal-regulated kinase 5 may play a neuroprotective role in hippocampal CA3/DG region after cerebral ischemia. J Neurosci Res 80, 391 399.
9. Sturla LM, Cowan CW, Guenther L, Castellino RC, Kim JY Pomeroy SL (2005) A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Res 65, 5683 5689.
10. Nishimoto S Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7, 782 786.
11. Bhat NR Zhang P (1999) Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J Neurochem 72, 112 119.
12. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW et al. (2000) Persistent activation of ERK1/2 contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275, 12200 12206.
13. Lesuisse C Martin LJ (2002) Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab 22, 935 950.
14. de Bernardo S, Canals S, Casarejos MJ, Solano RM, Menendez J Mena MA (2004) Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures. J Neurochem 91, 667 682.
15. Canals S, Casarejos MJ, de Bernardo S, Solano RM Mena MA (2003) Selective and persistent activation of extracellular signal-regulated protein kinase by nitric oxide in glial cells induces neuronal degeneration in glutathione-depleted midbrain cultures. Mol Cell Neurosci 24, 1012 1026.
16. Chen J, Rusnak M, Lombroso PJ Sidhu A (2009) Dopamine promotes striatal neuronal apoptotic death via ERK1/2 signaling cascades. Eur J Neurosci 29, 287 306.
17. Shirakawa H, Yamaoka T, Sanpei K, Sasaoka H, Nakagawa T Kaneko S (2008) TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Biophys Res Commun 377, 1211 1215.
18. Ho Y, Samarasinghe R, Knoch ME, Lewis M, Aizenman E DeFranco DB (2008) Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. Mol Pharmacol 74, 1141 1151.
19. Lu KT, Cheng NC, Wu CY Yang YL (2008) NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade. Crit Care Med 36, 917 922.
20. Zhang JZ, Jing L, Guo FY, Ma Y Wang YL (2007) Inhibitory effect of ketamine on phosphorylation of the extracellular signal-regulated kinase 1/2 following brain ischemia and reperfusion in rats with hyperglycemia. Exp Toxicol Pathol 59, 227 235.
21. Frasca G, Carbonaro V, Merlo S, Copani A Sortino MA (2008) Integrins mediate beta-amyloid-induced cell-cycle activation and neuronal death. J Neurosci Res 86, 350 355.
22. Hidalgo C Nunez MT (2007) Calcium, iron and neuronal function. IUBMB Life 59, 280 285.
23. Luo Y DeFranco DB (2006) Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem 281, 16436 16442.
24. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Graos MM, Carvalho RF, Carvalho AP Duarte CB (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK1/2 and PI3-kinase pathways. Cell Death Differ 12, 1329 1343.
25. Subramaniam S, Shahani N, Strelau J, Laliberte C, Brandt R, Kaplan D Unsicker K (2005) Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci 25, 2838 2852.
26. Subramaniam S, Strelau J Unsicker K (2008) GDNF prevents TGF-beta-induced damage of the plasma membrane in cerebellar granule neurons by suppressing activation of p38-MAPK via the phosphatidylinositol 3-kinase pathway. Cell Tissue Res 331, 373 383.
27. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179 185.
28. Swant JD, Rendon BE, Symons M Mitchell RA (2005) Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1. J Biol Chem 280, 23066 23072.
29. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R Bernhagen J (2006) Rapid and transient activation of the ERK1/2 MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 18, 688 703.
30. Virdee K, Xue L, Hemmings BA, Goemans C, Heumann R Tolkovsky AM (1999) Nerve growth factor-induced PKB/Akt activity is sustained by phosphoinositide 3-kinase dependent and independent signals in sympathetic neurons. Brain Res 837, 127 142.
31. Kamakura S, Moriguchi T Nishida E (1999) Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274, 26563 26571.
32. Terasawa K, Ichimura A, Sato F, Shimizu K Tsujimoto G (2009) Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 276, 3269 3276.
33. Stanciu M DeFranco DB (2002) Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J Biol Chem 277, 4010 4017.
34. Subramaniam S, Zirrgiebel U, von Bohlen Und Halbach O, Strelau J, Laliberte C, Kaplan DR Unsicker K (2004) ERK1/2 activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3. J Cell Biol 165, 357 369.
35. Mebratu Y Tesfaigzi Y (2009) How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8, 1168 1175.
36. Cummings BS Schnellmann RG (2002) Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302, 8 17.
37. Belmokhtar CA, Hillion J Segal-Bendirdjian E (2001) Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20, 3354 3362.
38. Volbracht C, Leist M, Kolb SA Nicotera P (2001) Apoptosis in caspase-inhibited neurons. Mol Med 7, 36 48.
39. Castro-Obregon S, Del Rio G, Chen SF, Swanson RA, Frankowski H, Rao RV, Stoka V, Vesce S, Nicholls DG Bredesen DE (2002) A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 9, 807 817.
40. Castro-Obregon S, Rao RV, del Rio G, Chen SF, Poksay KS, Rabizadeh S, Vesce S, Zhang XK, Swanson RA Bredesen DE (2004) Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK1/22, and Nur77. J Biol Chem 279, 17543 17553.
41. Wong JK, Le HH, Zsarnovszky A Belcher SM (2003) Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J Neurosci 23, 4984 4995.
42. Runden E, Seglen PO, Haug FM, Ottersen OP, Wieloch T, Shamloo M Laake JH (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 18, 7296 7305.
43. Lobner D Liot G (2004) Role of MAPK/ERK1/2 in neurotrophin-4 potentiation of necrotic neuronal death. Neurochem Res 29, 2303 2309.
44. Cande C, Cecconi F, Dessen P Kroemer G (2002) Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 115, 4727 4734. (Pubitemid 36054627)
45. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL et al. (1999) Activation of neuronal extracellular receptor kinase (ERK1/2) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10, 2411 2415.
46. Shahani N, Subramaniam S, Wolf T, Tackenberg C Brandt R (2006) Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J Neurosci 26, 6103 6114.
47. Guise S, Braguer D, Carles G, Delacourte A Briand C (2001) Hyperphosphorylation of tau is mediated by ERK1/2 activation during anticancer drug-induced apoptosis in neuroblastoma cells. J Neurosci Res 63, 257 267.
48. Harris FM, Brecht WJ, Xu Q, Mahley RW Huang Y (2004) Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279, 44795 44801. (Pubitemid 39430890)
49. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res Mol Brain Res 109, 45 55.
50. Jellinger KA Stadelmann C (2001) Problems of cell death in neurodegeneration and Alzheimer's disease. J Alzheimers Dis 3, 31 40.
51. Rapoport M Ferreira A (2000) PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. J Neurochem 74, 125 133.
52. Kulich SM Chu CT (2001) Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J Neurochem 77, 1058 1066.
53. Gomez-Santos C, Ferrer I, Reiriz J, Vinals F, Barrachina M Ambrosio S (2002) MPP+ increases alpha-synuclein expression and ERK1/2/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res 935, 32 39. (Pubitemid 34327842)
54. Zhu JH, Kulich SM, Oury TD Chu CT (2002) Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am J Pathol 161, 2087 2098.
55. Meloche S Pouyssegur J (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227 3239.
56. Upadhyay AK, Ajay AK, Singh S Bhat MK (2008) Cell cycle regulatory protein 5 (Cdk5) is a novel downstream target of ERK1/2 in carboplatin induced death of breast cancer cells. Curr Cancer Drug Targets 8, 741 752.
57. Alessandrini A, Namura S, Moskowitz MA Bonventre JV (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 96, 12866 12869.
58. Wang X, Wang H, Xu L, Rozanski DJ, Sugawara T, Chan PH, Trzaskos JM Feuerstein GZ (2003) Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J Pharmacol Exp Ther 304, 172 178.
59. Noshita N, Sugawara T, Hayashi T, Lewen A, Omar G Chan PH (2002) Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 22, 7923 7930.
60. Cho DG, Mulloy MR, Chang PA, Johnson MD, Aharon AS, Robison TA, Buckles TL, Byrne DW Drinkwater DC Jr. (2004) Blockade of the extracellular signal-regulated kinase pathway by U0126 attenuates neuronal damage following circulatory arrest. J Thorac Cardiovasc Surg 127, 1033 1040.
61. Wang Z, Chen X, Zhou L, Wu D, Che X Yang G (2003) Effects of extracellular signal-regulated kinase (ERK1/2) on focal cerebral ischemia. Chin Med J (Engl) 116, 1497 1503. (Pubitemid 37461663)
62. Kitagawa H, Warita H, Sasaki C, Zhang WR, Sakai K, Shiro Y, Mitsumoto Y, Mori T Abe K (1999) Immunoreactive Akt, PI3-K and ERK1/2 protein kinase expression in ischemic rat brain. Neurosci Lett 274, 45 48.
63. Irving EA, Barone FC, Reith AD, Hadingham SJ Parsons AA (2000) Differential activation of MAPK/ERK1/2 and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 77, 65 75.
64. Lennmyr F, Karlsson S, Gerwins P, Ata KA Terent A (2002) Activation of mitogen-activated protein kinases in experimental cerebral ischemia. Acta Neurol Scand 106, 333 340.
65. Fukunaga K Miyamoto E (1998) Role of MAP kinase in neurons. Mol Neurobiol 16, 79 95.
66. Grewal SS, York RD Stork PJ (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9, 544 553.
67. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14, 311 317.
68. Corbit KC, Foster DA Rosner MR (1999) Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol Cell Biol 19, 4209 4218.
69. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW Stork PJ (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392, 622 626.
70. Zhu D, Wu X, Strauss KI, Lipsky RH, Qureshi Z, Terhakopian A, Novelli A, Banaudha K Marini AM (2005) N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway. J Neurosci Res 80, 104 113.
71. Irving EA Bamford M (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22, 631 647.
72. Allen LF, Sebolt-Leopold J Meyer MB (2003) CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol 30, 105 116.